Status:
UNKNOWN
Training in Shared Decision-making of Cystic Fibrosis Centers Competences in the Treatment of CF Related Diabetes in Adult Patients
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Diabetes
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
Diabetes affects half of cystic fibrosis patients aged 30 years and older. It develops asymptomatically for a long time. Also, two options are possible: start insulin treatment now with the additional...
Eligibility Criteria
Inclusion
- Concerning the patient :
- Patient major
- Patient affected by cystic fibrosis
- Patient able to understand french
- Patient sable on Respiratory and nutritional status
- Patient with disorders of carbohydrate metabolism in the glucose tolerance test (OGTT)
- Patient with normal fasting blood sugar
- Concerning the health professionals :
- Medical and paramedical professionals practising in the adult Cystic Fibrosis Centers Competences (doctors, nurses, dieticians, psychologists, physiotherapists, etc...)
Exclusion
- Patient with transplant
- Patient who have received insulin therapy
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04891159
Start Date
September 1 2021
End Date
April 1 2023
Last Update
May 18 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CRCM Grenoble adulte - Hôpital Albert Michallon
La Tronche, France, 38700
2
CRCM Montpellier Mixte - Hôpital Arnaud de Villeneuve
Montpellier, France, 34295
3
CRCM Lyon adulte - Centre hospitalier Lyon Sud
Pierre-Bénite, France, 69495
4
CRCM Rennes adulte - Hôpital Pontchaillou
Rennes, France, 35033